BE BIOPHARMA
Be Biopharma is a biotech research company that develops a class of B cells as medicines.
BE BIOPHARMA
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2020-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.be.bio
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
182 M USD
Technology used in webpage:
SPF Oracle Cloud Mimecast Dyn Hosting CloudFloorDNS
Similar Organizations
FibroBiologics
FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells.
Frontier Medicines
Frontier Medicines is a developer of a chemoproteomics platform intended to further accelerate the path to drug discovery.
ImmPACT Bio
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Nitrase Therapeutics
Nitrase Therapeutics is developing drugs against newly discovered nitration enzyme(s).
Recludix Pharma
Recludix pharma is a developing platform to treat cancer patients.
ReCode Therapeutics
ReCode Therapeutics is a genetic medicines company developing targeted, disease-modifying therapies for life-limiting respiratory diseases.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Totus Medicines
Totus Medicines is a provider of chemical biology technologies by creating life-changing covalent drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bristol-Myers Squibb
Bristol-Myers Squibb investment in Series B - Be Biopharma
Atlas Venture
Atlas Venture investment in Series B - Be Biopharma
Alta Partners
Alta Partners investment in Series B - Be Biopharma
RA Capital Management
RA Capital Management investment in Series B - Be Biopharma
Longwood Fund
Longwood Fund investment in Series B - Be Biopharma
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Be Biopharma
Takeda Ventures
Takeda Ventures investment in Series B - Be Biopharma
Alta Partners
Alta Partners investment in Series A - Be Biopharma
Longwood Fund
Longwood Fund investment in Series A - Be Biopharma
RA Capital Management
RA Capital Management investment in Series A - Be Biopharma
Official Site Inspections
http://www.be.bio Semrush global rank: 3.34 M Semrush visits lastest month: 4.18 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Be Biopharma"
Our Company - Be Biopharma
Be Biopharma (“Be Bio”) is pioneering Engineered B Cell Medicines (BCMs) to dramatically improve the lives of patients who are living with Hemophilia B and other genetic diseases, …See details»
Life at Be Bio - Be Biopharma
Here at Be Bio we are on an important journey to unleash the power of cell therapies beyond cell-cell contact-dependent killing (e.g., CAR-T cells); we are developing a proprietary class of …See details»
Biotechnology Innovation Organization | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.See details»
Be Bio Announces $82 Million Financing and Transition to Clinical …
Oct 22, 2024 Be Bio was founded in October 2020, and is backed by ARCH Venture Partners, Atlas Venture, RA Capital Management, Alta Partners, Longwood Fund, Bristol Myers Squibb, …See details»
Be Bio Announces $82 Million Financing and Transition to
Oct 23, 2024 Concurrent with building out these later-stage functions, the Company will streamline its early research organization and related functions to focus resources on product …See details»
Be Biopharma Expands Leadership Team as Company Transitions …
Jan 4, 2024 Be Biopharma Expands Leadership Team as Company Transitions to Clinical Stage Organization. ... CAMBRIDGE, Mass.–(BUSINESS WIRE)–Be Biopharma, Inc. (“Be Bio”), a …See details»
Be Bio: $82 Million Raised To Discover And Develop Engineered B …
Oct 25, 2024 Patki joins from Rally Bio, where he served as Senior Vice President and Global Team Leader for asset development projects, with prior leadership experience at Alexion …See details»
Biotechnology Innovation Organization - Wikipedia
The Biotechnology Innovation Organization (BIO) is the largest advocacy association in the world representing the biotechnology industry. [1] [2] [3] It was founded in 1993 as the Biotechnology …See details»
BIO Member Company Facilities Map
BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. …See details»
Be Bio Announces Closing of $92M Series C Financing and …
CAMBRIDGE, Mass., January 15, 2025 – Be Biopharma, Inc. (“Be Bio” or “the Company”), a leader in B Cell Medicines (BCMs), today announced the closing of its $92M Series C …See details»
Biotechnology Innovation Organization | Foundation Directory
Dec 19, 2024 the biotechnology innovation organization (bio) represents approximately 1,000 companies and organizations in washington dc, state capitals, and international fora. bio is …See details»
BIO Partnering: the trusted way to request and schedule meetings …
As the pioneer for life sciences partnering, BIO Partnering has been the most trusted partner database and meeting platform in the industry for more than 25 years. BIO Partnering is a …See details»
Press Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell ...
Mar 20, 2006 About Dren Bio Dren Bio is a privately held, clinical-stage biopharmaceutical company pioneering the discovery and development of novel first-in-class antibody …See details»
BIO International Convention | June 16-19, 2025 | Boston
Jan 23, 2025 See the schedule of events for the 2025 BIO International Convention, June 16-19, 2025 at the Boston Convention and Exhibition Center.See details»
Establishing Canada’s first large-scale bioinnovation centre
2 days ago Today, the Honourable Darren Fisher, Member of Parliament for Dartmouth – Cole Harbour, announced a $5 million, non-repayable contribution to Neptune BioInnovation Inc. to …See details»
News Releases - Be Biopharma
Mar 3, 2025 Be Bio Announces Closing of $92M Series C Financing and Completes Transition to a Multi-Program, Clinical Stage Company. ... Read More about Be Biopharma Expands …See details»
Biological Organization – History, Levels, Importance
Nov 11, 2024 Levels of Organization and the Debate Between Mechanists and Vitalists The organicist movement arose partly in response to the mechanist and neovitalist debates. …See details»
Press Release: Sanofi to acquire Dren Bio’s bispecific
1 day ago About Dren Bio Dren Bio is a privately held, clinical-stage biopharmaceutical company pioneering the discovery and development of novel first-in-class antibody therapeutics for the …See details»
10 Levels of Biological Organization - BioExplorer.net
Jul 9, 2023 Levels of Biological Organization: Take a look around you. Life is found almost everywhere on Earth. The vast diversity of organisms present is indeed fascinating. Different …See details»
Our Platform - Be Biopharma
Our goal is to create a transformative new class of highly durable, off-the-shelf, redosable medicines that provide long-lasting production of therapeutic proteins: Engineered B Cell …See details»